| Entry |
|
|---|
| Name |
Valpromide (INN);
Depamide (TN) |
|---|
| Formula |
C8H17NO
|
|---|
| Exact mass |
143.131
|
|---|
| Mol weight |
143.2267
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG02035 Fatty acid antiepileptic
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiepileptic |
|---|
| Comment |
Fatty acid derivative
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AG Fatty acid derivatives
N03AG02 Valpromide
D02766 Valpromide (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG02035 Fatty acid antiepileptic
D02766 Valpromide
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 10
1 C1c C 20.0786 -15.7473
2 C1b C 20.0786 -14.3683
3 C1b C 18.8691 -16.4660
4 C5a C 21.2824 -16.4660
5 C1b C 18.8633 -13.6612
6 C1b C 17.6595 -15.7473
7 N1a N 21.2824 -17.8625
8 O5a O 22.4918 -15.7473
9 C1a C 16.4560 -16.4660
10 C1a C 17.6287 -14.3690
BOND 9
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 1
6 4 7 1
7 4 8 2
8 6 9 1
9 5 10 1
|
|---|
